ESCRIBÁ RUIZ, Pablo Vicente,BUSQUETS XAUBET, Xavier
申请号：
CL2017000988
公开号：
CL2017000988A1
申请日:
2017.04.20
申请国别(地区):
CL
年份:
2017
代理人:
摘要：
<； p >； This Invention Bertalanffy refers to hydroxy triacylglycerols, S & amp； A Synthesis, composition & amp； Pharmaceutical & eacute； utica and / or Nutraceuticals & eacute； utica comprising at least one of said hydroxy triacylglycerols,And an M & eacute； everything that comprises the Administration to the patient of Bertalanffy an amount effective Therapeutic uticamente & eacute； at least one of said hydroxy triacylglycerols or at least one of these Pharmaceutical compositions & eacute； Treatment and / or Nutraceuticals & eacute； for the treatment, Prevention and Bertalanffy or Treatment At least a chosen disease cancer, between C & nbsp；Diseases metab & acute； SAP / cardiovascular, neurological diseases and / or & acute； S / inflammatory regulation. <； / p >；LA SOLICITUD SE REFIERE A COMPUESTOS DERIVADOS DE HIDROXI-TRIACILGLICEROL, A UN PROCESO DE PRODUCCIÓN DE ESTOS, A UNA COMPOSICIÓN FARMACÉUTICA Y/O NUTRACÉUTICA QUE LOS COMPRENDE Y A SU USO EN EL TRATAMIENTO DEL CÁNCER, ENFERMEDADES METABÓLICAS, CARDIOVASCULARES, NEUROLÓGICAS E INFLAMATORIAS.
